www.wyicsapc.co.uk Open in urlscan Pro
2a07:7800::222  Public Scan

Form analysis
1 forms found in the DOM

GET https://www.wyicsapc.co.uk/

<form method="get" id="searchform" action="https://www.wyicsapc.co.uk/">
  <input type="text" name="s" id="s" placeholder="Enter keywords...">
  <input type="submit" class="submit" name="submit" id="searchsubmit" value="Search">
</form>

Text Content

COOKIES ON THE SOUTH WEST YORKSHIRE AREA PRESCRIBING COMMITTEE WEBSITE

We use cookies to ensure that we give you the best experience on our website. If
you continue without changing your settings, we'll assume that you are happy to
receive all cookies on the South West Yorkshire Area Prescribing Committee
website. However, if you would like to, you can change your cookie settings at
any time.

Continue Find out more
 * Cookie Policy | Privacy Policy | Sitemap | Contact us


NHS_WEST_YORKSHIRE_INTERGRATED_CARE_BOARD_LOGO_WEBSITE_SIZED


SELF CARE




DRUG CLASSIFICATIONS, SHARED CARE AND COMMISSIONING STATEMENTS

 * Classification Definitions
 * Search by individual drug or device
 * Search by drug or device classification
 * Shared Care Guidelines
 * Commissioning Statements


PREVENTING ANTIMICROBIAL RESISTANCE – PATIENT ADVICE

 * Antibiotic Awareness
 * Self Care – Introduction
 * Self Care – Adult Illness
 * Self-Care – Children illness
 * Self Care – Useful links


FOR CLINICIANS

 * Antimicrobial guidelines – updated January 2023
 * Wound Management Formulary
 * Prescribing guidelines
 * Medicines alerts & safety issues
 * Mental health
 * Respiratory resources
 * Generic & biosimilar medicines
 * Useful links


FOR PATIENTS AND PUBLIC

 * Inhaler leaflets for patients
 * Inhaler videos for patients
 * Patient Information
 * Home


FOR CARE HOME STAFF

 * Welcome to the Care Homes page


SWYAPC BUSINESS

 * Welcome to the SWYAPC Website

 * n Add shortcut to smartphone
 * 7Add to favourites
 * < Print this page

Home


HOME

Welcome to the SWYAPC website

Since August 2020 we have continued the business of the SWYAPC while working to
develop and establish a successor West Yorkshire ICS Area Prescribing Committee
which will take over from this committee and the Leeds APC.  This will align
prescribing classifications, amber guidelines and other prescribing guidance for
West Yorkshire providing a seamless approach for our patients.  

The last meeting of the SWYAPC took place on 7th March 2022.

Access to existing guidance and resources will be maintained on the SWYAPC
website until a functional successor website has been developed for WYAPC.

The information on these pages is intended as a guide only. Whilst we endeavour
to keep such information as up to date as possible, we make no claim as to its
total accuracy or completeness. Information is liable to change, and such
changes may not be mirrored in this site. We do not accept liability for any
loss or damage resulting from use of this site or reliance on its content.
External links lead to sites and pages over which we have no control, and which
we cannot verify for accuracy or content. The inclusion of a link on this
website should not be taken as an endorsement of the linked website, nor of the
accuracy or quality of the information on such sites.

Baby Formula – Alimentum Similac and Elecare Similac –  Abbott recalls two
infant formula powders for safety reasons – February 2022

Chair’s Action 23rd February 2023

Dexcom 1 – Glucose monitoring device – Do not prescribe – not yet classified –
interim classification prior to the ratification of a WY ICB Commissioning
Policy for CGM.

Chair’s Action 25th August 2022

Romosozumab – For treating severe osteoporosis – RED – NICE TA791.

Chair’s Action 28th April 2022

Cenobamate oral – For drug resistant epilepsy following initiation in a tertiary
epilepsy service – Specialist Initiation –  NICE TA753

Chair’s Action 16th February 2022

Paxlovid® – an antiviral medicine used for treating mild-to-moderate COVID – RED
classification. As the timescales did not fit in with the SWYAPC and ICS APC
meetings, the chair has approved Paxlovid as a ‘red’ drug.

 

 

Gender Dysphoria statement

To ensure a consistency of approach in WY&H, following GPs receiving requests
for medication to be prescribed following virtual consultations from a private
Gender Dysphoria clinic.  The following statement from the GMC guidance is to be
used by the GPs if approached:

“The ICS have been made aware of an external organisation which has its base of
practice outside of the UK recommending gender dysphoria treatments to patients
and asking GP practices to prescribe treatments for these patients. GP practices
are advised they should only prescribe on the recommendation of an experienced
gender specialist* who is registered within the UK. If you are unsure whether a
specialist working outside the NHS is suitably qualified, you are not obliged to
follow their recommendations”

*An experienced gender specialist will have evidence of relevant training and at
least two years’ experience working in a specialised gender dysphoria practice.

 

COVID-19

Please refer to the NHS link regarding any information you may need in relation
to COVID-19.

Valproate Pregnancy Prevention Programme

The following sections include new information about valproate and pregnancy:
Medicines alerts and safety issues; mental health; patient information.

 

Skin preparations (including emollients)

West Yorkshire Fire & Rescue Service has produced YouTube Videos for the public
and patients and one for healthcare professionals warning that skin
preparations can increase the risk of a fire developing. The YouTube videos have
been added to the following sections of the website for information and
discussion:  Medicines Alerts and Safety Issues, Patient Information and Care
Homes. There is also information on the Fire Service’s website. The MHRA has
issued a press release.

Safe use of emollients video

Safe use of emollients video

A version with Welsh subtitles is available on YouTube

Skin creams, sometimes known as emollients are used by many people every day to
help manage different dry skin conditions such as eczema, psoriasis and
ichthyosis.

The creams are easily transferred from skin onto clothing, bedding and bandages.
Tests and research have shown that the dried-on cream makes the fabric more
flammable and the resulting fire burns quickly and intensely, resulting in
serious injury or death.

It’s important for anyone using these creams to avoid any naked flame.

If you use an emollient or skin cream to treat a dry skin condition, please
follow this advice.

Avoid smoking

Do not smoke, use naked flames or get near to anything which may cause a fire
whilst wearing clothing or a bandage that has been in contact with skin creams.

If this is not possible, you must take steps to ensure you are safe when you
smoke or use naked flames. For example, by using a flameless lighter or
e-cigarette, and removing long sleeved or baggy clothing before using a gas hob.

Change and wash clothes and bedding

Change and wash your clothes and bedding frequently to reduce the build-up of
skin cream. However, remember that whilst washing your clothing and bedding even
at high temperatures might reduce the build-up, it does not remove it completely
and the danger may remain.

Keep cream off furniture

Be careful to make sure the skin cream does not get onto the fabric of armchairs
or other furniture, cushions and blankets. Be aware that the cream can transfer
from your skin onto the fabric of furniture when you are sitting or lying on it.

Tell relatives and carers

Tell your relatives or carers about your treatment and ask how they can help you
to reduce the risk. Download the leaflet on this page for them.

Tell your healthcare professional

Tell your doctor, nurse or pharmacist if you normally smoke. They will be able
to offer you help and advice to stop smoking.

Further advice and resources

For advice and guidance to help minimise the risk when using emollients, talk to
your local Fire and Rescue Service. Digital resources and further information
about the campaign to help fire services promote the campaign is available to
download below.

MHRA and NFCC emollients leaflet A5 (PDF, 1.43MB, 2 pages) – 2 page PDF leaflet

MHRA and NFCC emollients poster with text A3 (PDF, 2.01MB, 1 page) – A3 poster
with footer text and space for your logo

MHRA and NFCC emollients poster background A3 (PNG, 8.55MB) – A3 background
poster image for use in MS Office and DTP software

MHRA and NFCC emollients alert sticker (PNG, 5.58KB) – 70mm x 35mm sticker
graphic

MHRA and NFCC emollients toolkit presentation pack (MS Powerpoint Presentation,
17.1MB) – Slide presentation pack

 


TEMPLATES

Download the RAG submission pro forma.
Download the SCG template.
Download the RED DRUG ONLY SUMMARY SHEET.




QUICK LINKS

 * Recently added


NEWS ARCHIVE

 * November 2019
 * October 2019


OUR PARTNERS

 * Bradford District and Craven CCG
   
 * Bradford District Care NHS Foundation Trust
 * 
   href="http://www.calderdaleccg.nhs.uk">NHS Calderdale CCG
 * Calderdale and Huddersfield NHS Foundation Trust
 * Locala Community Partnerships
 * The Mid Yorkshire Hospitals NHS Trust
 * NHS Kirklees CCG
   href="http://www.southwestyorkshire.nhs.uk/">South West Yorkshire Partnership
   NHS Foundation Trust
 * Spectrum Community Health CIC
 * NHS Wakefield CCG
 * Airedale NHS Foundation Trust

   
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 *